| Primary information |
|---|
| sequence ID | Seq_1184 |
| Peptide sequence | DDPDAPLQPVTPLQLFEG |
| CancerPDF_ID | CancerPDF_ID897, CancerPDF_ID1906, CancerPDF_ID8743, |
| PMID | 19795908,21136997,24694173 |
| Protein Name | Complement C4-B,Complement C4-B,Complement C4-A |
| UniprotKB Entry Name | CO4B_HUMAN,CO4B_HUMAN,CO4A_HUMAN |
| Fluid | Plasma,Serum,Ascites fluid |
| M/Z | 976.48,1950.95747,NA |
| Charge | 2,1,1 |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,LTQ-Orbitrap XL |
| Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,X tandem for peptide identification |
| Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,NA |
| Labelled/Label Free | Labelled,Label Free,Label Free |
| FDR | less than 7%,NA,NA |
| CancerPDF_ID | CancerPDF_ID897, CancerPDF_ID1906, CancerPDF_ID8743, |
| p-Value | NA,NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),"X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
| Length | 18,18,18 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Ovarian cancer |
| Database | NCBI refseq Protein Database,SwissProt Database,"IPI00032258,IPI00418163,IPI00643525,IPI00654875,IPI00843913,IPI00887154,IPI00889723,IPI00892547,IPI00892604,IPI00937598" |
| Modification | NA,NA,NA |
| Number of Patients | "42 normal, 28 patients",30 patients and 30 healthy controls,3 ovarian cancer patient and 3 non cancerous control |
| Regulation | NA,NA,Uniquely expressed in ovarian cancer patient |
| Validation | NA,Leave One out Cross validation,NA |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |